Theodore A. Boutacoff Appointed President CEO of

Theodore A. Boutacoff Appointed President CEO of IRIDEX

MOUNTAIN VIEW, Calif., Oct. 17, 2007 IRIDEX Corporation (Nasdaq: IRIX) announced today that

Barry Caldwell has resigned as the Company s President and Chief Executive Officer, and as a member

of the Board of Directors, effective as of October 16, 2007. The Board of Directors has appointed

Theodore A. Boutacoff, who is currently a member and Chairman of the Board of Directors, to serve

as the Company s President and Chief Executive Officer. Prior to Mr. Caldwell s two year tenure,

Mr. Boutacoff had been the Company s President and Chief Executive Officer since co-founding the

Barry has worked hard during his tenure at IRIDEX, Mr. Boutacoff commented, We wish him the best

of success in his future endeavors.

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable

laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the

aesthetics market. IRIDEX products are sold in the United States through a direct sales force and

internationally through a combination of a direct sales force and a network of approximately 97

independent distributors into 107 countries.

Source: IRIDEX Corporation

CONTACT: Larry Tannenbaum, Chief Business Officer of IRIDEX Corporation,

Web site: http://www.iridex.com